Latest Virology Stories
A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma. Tackling latent HIV in the immune system is critical to finding a cure for AIDS. The results were presented today at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle, Washington. While current antiretroviral therapies can very effectively control virus levels, they can never...
In what may prove to be a major step forward for the treatment of HIV-1 infection, scientists have discovered an effective way to eliminate a notoriously persistent form of the virus that does not respond to current therapies. The research, published online by Cell Press on March 8th from the journal Immunity, describes a vaccination strategy that may be essential for successful eradication efforts and should therefore be considered for future clinical trials. Current antiretroviral...
Using human immune system cells in the lab, AIDS experts at Johns Hopkins have figured out a way to kill off latent forms of HIV that hide in infected T cells long after antiretroviral therapy has successfully stalled viral replication to undetectable levels in blood tests. In a report to be published in the journal Immunity online March 8, the Johns Hopkins team describes a vaccination strategy that boosts other immune system T cells and prepares them to attack HIV, before readying the...
As National Women and Girls HIV/AIDS Awareness Day is commemorated March 10, an expert at Baylor College of Medicine emphasized that arming young women with the right information is key in preventing and managing the disease. "It's important for both men and women to be aware of the risk of getting HIV/AIDS, as well as other sexually transmitted infections. But at the Baylor Teen Health Clinic we do have certain health messages related to both prevention and disease management that we...
An Atlanta research collaboration may be one step closer to finding a vaccine that will provide long-lasting protection against repeated exposures to human immunodeficiency virus (HIV). Scientists at Emory University and GeoVax Labs, Inc. developed a vaccine that has protected nonhuman primates against multiple exposures to simian immunodeficiency virus (SIV) given in three clusters over more than three years. SIV is the nonhuman primate version of HIV. Harriet L. Robinson, PhD, chief...
ATLANTA, March 7, 2012 /PRNewswire/ -- Harriet L. Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), a biotech company specializing in the development of HIV/AIDS vaccines, announced the results of a study suggesting that scientists may be one step closer to a vaccine that protects against multiple exposures to HIV infections. The study results were unveiled by Dr. Robinson during a presentation in Seattle at the 2012 Conference on...
More Than Half of Patients Found to Have Long Gaps in Between Appointments Only about 75 percent of HIV/AIDS patients in the United States remain in care consistently, according to new research from the Perelman School of Medicine at the University of Pennsylvania published online this week in AIDS. The study of patients across the United States is the first to provide a comprehensive national estimate of HIV care retention and information about patients who are most likely to continue...
NEW BRUNSWICK, N.J., March 6, 2012 /PRNewswire-USNewswire/ -- Congressman Donald Payne was elected to Congress when the AIDS epidemic was at its worst, life saving medications were unavailable, and little was known about the science of HIV treatment. He witnessed first hand the devastating impact of HIV/AIDS in the communities he was elected to represent. In response, Congressman Payne worked to increase awareness and funding for HIV/AIDS. He was a tireless supporter of research,...
Leading AIDS experts at Johns Hopkins and other institutions around the world have issued new guidelines to promote entry into and retention in HIV care, as well as adherence to HIV treatment, drawn from the results of 325 studies conducted with tens of thousands of people infected with HIV, the virus that causes AIDS. The guidelines are believed to be the first ever to focus exclusively on how best to get those newly diagnosed with HIV into treatment plans and to help them adhere to...
NEWARK, Del., Feb. 29, 2012 /PRNewswire/ -- iBio, Inc. (NYSE AMEX: IBIO) today announced issuance of a US patent covering the use of iBio's proprietary fusion-protein technology in combination with influenza virus antigens for vaccine product applications. The invention comprises the use of lichenase in an adjuvant-like role to improve the performance of vaccines. This approach was developed by the Fraunhofer USA Center for Molecular Biotechnology (FhCMB), iBio's research...
Latest Virology Reference Libraries
Virology Journal is an open-access peer-reviewed medical journal published by BioMed Central. It covers research related to viruses and the prevention of viral infection (including vaccination, the use of antiviral agents, and gene therapy). Virology Journal was established in 2004 and is edited by Robert F. Garry. The goal of the journal is to cover rapid communications amongst virologists. The journal has not been published without controversy, however. On 21, July 2010, the journal...
Virology is a peer-reviewed academic journal covering basic research into viruses affecting animals, plants, bacteria and fungi. It includes the molecular biology, structure, assembly, pathogenesis, immunity and interactions viruses have with the host cell. The journal also covers aspects of control and prevention, as well as viral vectors and gene therapy. Virology was established in 1955 and is now published bi-weekly by the Academic Press imprint of Elsevier. Subscribers of Virology...
A virus is a small infectious agent that replicates inside the living cells of organisms. It is a small infectious agent that can replicate only inside the living cells of organisms. Most are too small to be seen by anything but a microscope and they infect all organisms from animals to plants to bacteria. The first one discovered was the tobacco virus in 1898. Since then around 5,000 viruses have been described in detail although there are millions of different types. They are found in...
Vesicular stomatitis virus (VSV) is a virus in the family Rhabdoviridae. Rabies is in the same family. VSV infects insects and animals and is important to farmers in certain regions of the world where it can infect cattle. It is a common laboratory virus used for studying the Rhabdoviridae family and viral evolution. It is the prototypic member of the vesiculovirus genera of the Rhabdovirus family. The genome is a single molecule of negative-sense RNA that encodes five major proteins.
Tobacco mosaic virus (TMV) is a positive-sense single stranded RNA virus that infects plants, namely tobacco and other members of the family Solanaceae. It causes characteristic patterns on the leaves. In 1930 it was determined that an infectious agent was determined to be a virus. Adolf Mayer first described the disease in 1883. The disease can be transferred between plants similar to bacterial infections. Dimitri Ivanovski was the first to show that infected sap remained infectious even...
